BioAtla Faces Delisting Concerns
Ticker: BCAB · Form: 8-K · Filed: May 16, 2025 · CIK: 1826892
Sentiment: bearish
Topics: delisting, listing-standards
TL;DR
BioAtla might get delisted, check the listing rules.
AI Summary
BioAtla, Inc. filed an 8-K on May 16, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event reported on May 12, 2025. The company is incorporated in Delaware and its principal executive offices are located at 11085 Torreyana Road, San Diego, California.
Why It Matters
This filing indicates potential issues with BioAtla's continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall financial stability.
Key Players & Entities
- BioAtla, Inc. (company) — Registrant
- May 12, 2025 (date) — Earliest event reported
- May 16, 2025 (date) — Date of report
- 11085 Torreyana Road, San Diego, California (location) — Principal Executive Offices
FAQ
What specific listing rule or standard has BioAtla, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that BioAtla, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the earliest date of the event reported in this 8-K filing?
The earliest event reported in this filing is dated May 12, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on May 16, 2025.
Where are BioAtla, Inc.'s principal executive offices located?
BioAtla, Inc.'s principal executive offices are located at 11085 Torreyana Road, San Diego, California.
What is the Commission File Number for BioAtla, Inc.?
The Commission File Number for BioAtla, Inc. is 001-39787.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 regarding BioAtla, Inc. (BCAB).